| Acceptance rate | 46% |
|---|---|
| Time to first decision | 20 days* |
| Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
Accepted Manuscripts
Topical apigenin as a promising therapeutic agent for psoriasis: evaluating efficacy alone and in combination with clobetasol in an ımiquimod-induced model of psoriasis in mice
DOI : 10.23893/1307-2080.APS6240